In thyroid and prostate cancer cells TREM1 expression is regulated by epigenetic modifications, specifically hypomethylation of CpG site Cδ06196379 in the TREM1 promoter region and has significant prognostic value in thyroid tumors (64). Here, TREM1 is linked to prostate cancer.